We report the characterization of a nucleolar localization sequence (NoLS) that targets the green fluorescent protein (GFP) into the granular component (GC) of nucleoli. This NoLS interacts in vitro specifically and directly with the major nucleolar protein B23 and more precisely with the region of B23 including the two acidic stretches. The affinity of NoLS for B23 is stronger than that of the HIV-1 Rev protein in vitro. Moreover, B23-NoLS interaction occurs also in vivo. Indeed, 1) NoLS confers on the GFP the behavior of B23 throughout the cell cycle, 2) the GFP-NoLS fusion and B23 remain colocalized after drug treatments, 3) a selective delocalization of B23 from nucleoli to nucleoplasm induces a concomitent delocalization of the GFP-NoLS fusion, and 4) the fusion of NoLS to fibrillarin makes it possible to colocalize fibrillarin and B23. Interestingly, by fusing NoLS to fibrillarin, both fibrillarin and the fibrillarin partner Nop56 are mislocalized in the GC of nucleoli. Similarly by fusing the NoLS to MafG, part of the nuclear transcription factor NF-E2 composed of both MafG and p45 NF-E2, NF-E2 is re-directed from the nucleoplasm to the nucleoli. Thus, we propose that NoLS may be used as a tool to visualize and prove protein interactions in a cellular context. 3
Introduction
The architecture of the nucleus is complex and the nuclear functions are precisely located in the nuclear volume. Morphologically distinct structures or nuclear bodies are present. They correspond to specialized domains implicated in essential processes such as transcription and splicing (Matera, 1999; Spector, 2001; Strouboulis and Wolffe, 1996) , or represent in the case of the nucleolus the site of ribosome biogenesis (Mélèse and Xue, 1995) . This complicated architecture was proposed to be linked to the dynamics of proteins and RNP complexes in the nucleus (Misteli, 2001; Phair and Misteli, 2000) . In the nucleoplasm, the high mobility of proteins would ensure their diffusion and availability throughout the nucleus. In nuclear bodies the mobility of proteins is reduced most probably by interactions with partners. This determines a residence time based on affinities and functions of the proteins (Chen and Huang, 2001; Dundr et al., 2004; Snaar et al., 2000) . If this model based on analyses of the nuclear traffic in living cells is correct, protein interactions should govern their nuclear distribution. By modifying the normal affinity of proteins it might be possible to create experimental interactions that would provide information and permit analysis of the model.
The nucleolus is the paradigm of functional compartmentation in the nucleus (Strouboulis and Wolffe, 1996) . Ribosomal RNAs (rRNAs) are synthesized, processed and assembled with ribosomal proteins to form the small 40S and large 60S pre-ribosome subunits in the nucleolus (for a review, see Fatica and Tollervey, 2002; Gébrane-Younès et al., 2005; Hernandez-Verdun, 2006; Shaw and Jordan, 1995) . The dynamic integration of these processes generates a typical nucleolar organization revealing the compartmentation of the different steps. Three main specific components are observed by electron microscopy (Scheer and Hock, 1999) , the fibrillar centers (FCs), the dense fibrillar component (DFC), and the granular component (GC). In the active nucleolus, the early rRNA processing proteins are 4 associated with transcripts during elongation and localized in the internal part of the nucleolus, i.e. in the DFC. The processing proteins associated with late steps of rRNA processing are localized in the external region of the nucleolus, i.e. in the GC.
Protein B23 (NPM, nucleophosmin, numatrin or NO38) is an abundant phosphoprotein localized mainly in the nucleoli during interphase, at the chromosome periphery during mitosis, and in foci called prenucleolar bodies (PNBs) at the exit from mitosis. It is a multifunctional protein that has nucleic acid binding, ribonuclease and molecular chaperone activities. By mapping the functional domains of B23, it was found that the N-terminal domain of B23 is necessary and sufficient to bind nucleic acids, the molecular chaperone activity is contained in the N-terminal half of the protein, and the central region of the molecule is required for ribonuclease activity (Hingorani et al., 2000; Szebeni et al., 2003) . The C-terminal region of B23 is preferentially associated with 28S pre-rRNA and its ribonuclease activity processes the internal transcribed spacer 2 of the pre-rRNA (Huang et al., 2005; Itahana et al., 2003; Savkur and Olson, 1998) . The chaperone activity of B23 is controlled by protein kinase CK2 and is most probably linked to the ability of B23 to form large oligomers in native conditions (Herrera et al., 1996; Szebeni et al., 2003) . In addition, B23 interacts with other nucleolar proteins such as nucleolin (Li et al., 1996) , protein p120 (Valdez et al., 1994) , ARF (Korgaonkar et al., 2005) and the HIV-1 Rev protein (Fankhauser et al., 1991) . In this latter case B23 could serve as molecular chaperone for Rev (Olson, 2004) . In addition, it was also proposed that B23 could play a role in nucleocytoplasmic transport since it can shuttle between nucleus and cytoplasm (Borer et al., 1989; Fankhauser et al., 1991) . B23 is phosphorylated before mitosis and this modification reduces RNA binding by B23 (Okuwaki et al., 2002) . This suggests that phosphorylation at the beginning of mitosis may promote B23 translocation from nucleoli to chromosome periphery. Interestingly, mutated B23 genes were found in a number of cancers and their implication in haematological 5 disorders was demonstrated (Grisendi et al., 2005) . B23 therefore appears to be a key protein in ribosome biogenesis and cell cycle.
In the case of nucleolar targeting of viral proteins, it was proposed that a nucleolar sequence signal (NoLS) could be involved (Dang and Lee, 1989; Kubota et al., 1989; Siomi et al., 1988) . This is not a particularity of viral proteins since similar sequences were also found in several endogenous nucleolar proteins (Dang and Lee, 1989; Korgaonkar et al., 2005; Song and Wu, 2005; Valdez et al., 1994; Weber et al., 2000) . In the present study, we have characterized a novel protein sequence that targets the green fluorescent protein (GFP) to the GC of nucleoli. This sequence designated NoLS interacts both in vitro and in vivo with B23.
In addition, we show that on one hand, by fusing the NoLS to fibrillarin, both fibrillarin and Nop56, another member of the core proteins of the box C/D snoRNP complexes, are relocalized from the DFC to the GC of nucleoli. On the other hand, by fusing the NoLS to MafG, a subunit of the transcription factor NF-E2 composed of MafG and p45 NF-E2 (Tramier et al., 2002) , NF-E2 is re-directed from the nucleoplasm to the GC of the nucleoli.
Thus, we demonstrate here the capability to relocalize nuclear complexes by adding an affinity for B23 to one subunit of the complex and therefore, we propose that such a B23-interacting sequence may be used as tool to visualize and to prove protein interactions in a cellular context by fluorescence microscope observations.
Results

A novel nucleolar localization sequence
During PCR-amplication of the DNA sequence encoding human Sirtuin 1, a mutant was generated which showed a nucleolar localization when expressed fused to GFP in HeLa cells.
The analysis of the DNA sequence of this mutant revealed a misreading of the DNA polymerase having led to the loss of four nucleotides (nt 262-265) of the Sirtuin 1-coding DNA sequence and consequently, to a change in reading frame (Fig. 1A) . Therefore, the resulting mutant protein corresponds to the first 87 amino acids of Sirtuin 1 followed by a "synthetic" sequence of 93 amino acids corresponding to the Sirtuin 1 DNA sequence (nt 266-544). By subcloning both parts of this mutant protein separately into a GFP-fusion plasmid, we observed that the first 87 amino acids of Sirtuin 1 (∆ Sirtuin 1) expressed fused to the GFP in HeLa cells did not show any obvious nucleolar localization contrary to the "synthetic" sequence which was able to address the GFP to the nucleolus. The new sequence (Fig. 1A,B) was therefore designated NoLS. This novel NoLS possesses no significant homology with the NoLSs previously described except for the presence of a stretch of basic residues (Fig. 1B , in red) as already reported for other nucleolus-localizing proteins.
To delineate this NoLS, different constructs were generated (Fig. 1C) and expressed in HeLa cells as GFP fused proteins (Fig. 1D) . Undoubtedly, the stretch of basic residues (in red Fig. 1B,C) is strongly implicated in nucleolar localization. Indeed, only the constructs NoLS, NoLS/33-93, NoLS/31-63 and NoLS/1-50 which possessed the stretch of basic residues were localized mostly if not exclusively in nucleoli, whereas the other constructs were not (NoLS/51-93) or only slightly (NoLS/1-32) enriched in nucleoli (Fig. 1D) . However, the entire sequence of NoLS seems to be implicated in nucleolar localization. On one hand, the construct NoLS/1-32 was also slightly enriched in nucleoli and on the other hand, even if the 7 construct NoLS/51-93 did not exhibit nucleolar localization (Fig. 1Dk) , the C-terminal region of NoLS appeared to facilitate targeting of the GFP to the nucleolus as observed by comparing the localization of NoLS/33-93 to that of NoLS/31-63 ( Fig. 1Dc and Di). Both constructs were localized in nucleoli but in the absence of the C-terminal end of NoLS (Fig. 1Di) , a certain level of nucleoplasmic labeling was also observed contrary to what occurred in the presence of the C-terminal end (Fig. 1Dc) . For these reasons, the complete NoLS was used for all subsequent experiments.
The novel NoLS interacts specifically and directly with B23 in vitro
To further understand how GFP-NoLS localized specifically in nucleoli and since previous studies had shown that several NoLSs interact with the major nucleolar protein B23 in vitro, we examined by glutathione S-tranferase (GST) pull down experiments the interaction between B23 and the novel NoLS ( Fig. 2A) . For this purpose, a GST-NoLS fusion was generated and pull down assays were carried out on whole cell extracts. As shown in Fig. 2A , analysis by Western blot of the bound proteins revealed that B23 interacts with the NoLS contrary to other nucleolar proteins such as Nopp140, nucleolin the other major nucleolar protein, and Nop52. The interaction between B23 and the NoLS is direct as demonstrated by GST-NoLS pull down assays carried out on purified B23 (Fig. 2B) . To determine the region within B23 required for B23-NoLS interaction, various B23 truncation mutants were generated ( The novel NoLS has a stronger affinity for B23 than for HIV-1 Rev in vitro
To evaluate the strength of the B23-NoLS interaction, we compared NoLS to the HIV-1 Rev protein, previously identified as a B23-interacting protein localized in the nucleolus. For this purpose, the same amounts of GST, GST-NoLS and GST-Rev were bound to sepharose beads and incubated for increasing times with the same whole HeLa cell extracts. After the GST pull down assays, the bound proteins were resuspended in SDS-PAGE sample buffer, electrophoresed and analyzed by coomassie blue staining to check that no significant loss of GST, GST-NoLS and/or GST-Rev had occurred during the experiments. In parallel, the sames samples were electrophoresed, Western-blotted onto nitrocellulose membranes and B23 was detected and quantified. As illustrated for a representative experiment (Fig. 3A,B ), B23 interacts with both NoLS and Rev but the B23-NoLS interaction occurred more rapidly and the amount of bound B23 was higher than in the B23-Rev interaction. Indeed, the comparison of the amounts of B23 bound to NoLS and to Rev (Fig. 3B ) reveals that the amount of B23 bound to NoLS was 4 times greater than that bound to Rev after 1.5 hours, 3 times after 3 hours and 2.5 times after 20 hours of incubation. The fact that the NoLS exhibits a strong affinity for B23 in vitro prompted us to verify the B23-NoLS interaction in vivo.
The novel NoLS interacts specifically with protein B23 in vivo
To precisely locate NoLS in nucleoli and to determine whether this localization is compatible with B23-NoLS interaction in vivo, we localized the GFP-NoLS fusion together with endogenous fibrillarin and B23 in interphasic HeLa cells. As shown Fig. 4A , fibrillarin known to be localized in the DFC of nucleoli did not colocalize with GFP-NoLS. Conversely B23, mostly located in the GC of nucleoli, appeared to strictly colocalize with GFP-NoLS indicating that GFP-NoLS is mostly localized in the GC of nucleoli. In addition, this colocalization is in agreement with the fact that interaction between B23 and NoLS occurs in vivo. Concerning mitosis, the behavior of GFP-NoLS appeared to be similar to that of B23 (Fig. 4B) . Indeed, as is well known for B23, GFP-NoLS was enriched at the periphery of chromosomes during metaphase ( Fig. 4Ba-d ) and recruited in PNBs at telophase before being relocated in new nucleoli formed in early G1 . Therefore the NoLS confers on GFP a localization similar to that of B23 throughout the cell cycle.
The localization of NoLS during the cell cycle is compatible with B23-NoLS interaction in vivo. This is reinforced by the fact that the colocalization of both NoLS and B23 was maintained when HeLa cells were treated with drugs inducing a dramatic reorganization of the nucleolus (Fig. 5A ) and hence relocalization of nucleolar proteins. Indeed after actinomycin D treatment that inhibits rDNA transcription and consequently induces nucleolar reorganization (Hadjiolov, 1985) , NoLS is colocalized with B23 ( Fig. 5Aa-d ) and excluded from caps where fibrillarin is located ( Fig. 5Ae-h ). Similarly, after treatment with the cyclin-dependent kinase (CDK) inhibitor roscovitine that also induces dramatic disorganization of the nucleolus (Sirri et al., 2002) , NoLS is still observed colocalized with B23 ( Fig. 5Ai -l) but not with fibrillarin ( Fig. 5Am-p) .
To prove B23-NoLS interaction in vivo, a human B23 mutant, designated mutant A by Falini and coworkers (Falini et al., 2005) was used to selectively exclude B23 from the nucleolus and to follow the localization of NoLS. This B23 mutant corresponds to a substitution of 11 novel amino acids for the seven C-terminal residues of the wild type B23 generating a consensus nuclear export signal (NES). This B23-NES mutant localizes in the cytoplasm of interphasic NIH-3T3 cells when expressed fused to GFP in a Crm1-dependent manner (Falini et al., 2006) . As previously reported (Falini et al., 2006) , in the presence of the Crm1-inhibitor leptomycin B, B23-NES relocates in the nucleus and is mostly excluded from the nucleoli (Fig. 5Ba,d ). Interestingly, most probably due to the capability of B23 to multimerize, after leptomycin B treatment the endogenous B23 is delocated from nucleoli in NIH-3T3 cells that express B23-NES, whereas the endogenous B23 remains localized in nucleoli in cells which do not express B23-NES after the same treatment ( Fig. 5Ba-c) .
Similarly in NIH-3T3 cells expressing B23-NES and treated with leptomycin B, most of NoLS leaves the nucleoli and localizes in the nucleoplasm ( Fig. 5Bd-f ). Since the selective delocalization of the endogenous B23 from nucleoli to nucleoplasm similarly modifies the localization of NoLS, we conclude that B23-NoLS interaction occurs in vivo. Consequently, we propose that fusing the NoLS to GFP confers on GFP a high affinity for B23. This affinity is maintained throughout the cell cycle, and therefore the GFP-NoLS fusion is able to interact specifically with B23 in vivo and to adopt the behavior of B23 during interphase as well as during mitosis.
The novel NoLS may be used as a new tool to visualize protein interactions in the cell nucleolus When fused to GFP, the novel NoLS is able to target GFP to the nucleolus by conferring on the GFP a high affinity for the nucleolar protein B23. However, it may be assumed that GFP does not possess any particular affinity in eukaryotic cells and therefore that modifying its localization is easier than for physiological proteins. Consequently, it may be asked whether addition of the NoLS to a physiological nucleolar protein could modify the localization of this protein. To answer this question, we localized both fibrillarin-GFP fusion and fibrillarinNoLS-GFP fusion together with B23 (expressed as DsRed-B23 fusion) in interphasic HeLa cells. As shown Fig. 6a-d , fibrillarin known to be localized in the DFC of nucleoli was not observed colocalized with B23 known to be mostly located in the GC of nucleoli. Conversely fibrillarin-NoLS appeared to strictly colocalize with B23 ( Fig. 6e-h) indicating that the addition of the NoLS to fibrillarin makes it possible to relocalize fibrillarin from the DFC to the GC of nucleoli, i.e. to confer on fibrillarin the same localization as B23.
It may also be asked whether the addition of NoLS to one subunit of a nucleolar protein complex could modify the localization of the entire complex. In this case, NoLS might be used as tool to visualize and to prove protein interactions in the nucleolus by adding NoLS to one subunit of a nucleolar protein complex and determining whether the other subunits of the complex are mislocalized. To address this question, we checked the effect of the mislocalization of fibrillarin in the GC of nucleoli, i.e. when expressed as fibrillarin-NoLS, on the localization of Nop56, another member of the core proteins of the box C/D snoRNP complexes. We first verified that both fibrillarin and the fibrillarin partner Nop56 were colocalized in the DFC of nucleoli when coexpressed in interphasic HeLa cells as fibrillarin-GFP and DsRed-Nop56 fusions (Fig. 6i-l) . The colocalization of both proteins was maintained when fibrillarin-NoLS and Nop56 were coexpressed in interphasic HeLa cells (Fig. 6m-p) showing that the mislocalization of fibrillarin in the GC of nucleoli induces the mislocalization of its partner Nop56. The relocalization of Nop56 into the GC of nucleoli when it was coexpressed with fibrillarin-NoLS was clearly due to the interaction between Nop56 and fibrillarin. Indeed no relocalization was observed for Nopp140, a protein that is not a member of the core proteins of the box C/D snoRNP complexes. As well established, fibrillarin and Nopp140 were colocalized in the DFC of nucleoli in interphasic HeLa cells (Fig. 6q-t ), but this colocalization was no longer maintained when fibrillarin delocalized into the GC of nucleoli (Fig. 6u-x) . In addition, the fact that the localization of Nopp140 was not modified in cells expressing fibrillarin-NoLS also indicated that the nucleolar morphology was maintained. The expression of fibrillarin-NoLS did not induce disappearance of DFC and consequently a general delocalization of proteins of the DFC.
The novel NoLS may be used as a new tool to visualize protein interactions in the cell nucleus When fused to the fibrillarin, NoLS is able to delocalize fibrillarin from the DFC to the GC of nucleoli by conferring on fibrillarin high affinity for B23. Moreover, the addition of NoLS to one subunit of a protein complex could modify the nucleolar localization of the complex.
Consequently, it may be asked whether addition of NoLS to a nuclear protein could modify the localization of the protein and target it to the nucleolus and whether the addition of the NoLS to one subunit of a nuclear protein complex could target the entire complex to the nucleolus. Thus, the NoLS might be used as tool to visualize and to prove protein interactions in the nucleus.
To answer these questions, the transcription factor NF-E2 composed of two subunits, MafG and p45 NF-E2, was used as model of a heterodimeric nuclear protein. These two protein subunits were produced as GFP-P45 and DsRed-MafG fusions and NoLS was added to the amino-terminus of MafG to generate the DsRed-NoLS-MafG fusion. We first verified that the GFP-P45 and DsRed-MafG fusions exhibited the expected localization when expressed in HeLa cells. Indeed, as previously reported (Tramier et al., 2002) , both proteins are localized in the nucleus and are largely excluded from nucleoli as observed by comparing their position to that of B23 (Fig. 7a-d,e-h ). More interestingly, the DsRed-NoLS-MafG fusion localized in nucleoli and the coexpression of both DsRed-NoLS-MafG and GFP-B23 showed a strict colocalization of both proteins (Fig. 7i-l) . Therefore, NoLS made it possible to modify the localization of MafG and to target it to nucleoli. The capability of NoLS to relocalize a nuclear protein to the nucleoli and more precisely to the GC of the nucleoli where 13 B23 is located, was also verified for CDK9 (our unpublished data).
Concerning the localization of the MafG partner P45, coexpression of both DsRedNoLS-MafG and GFP-P45 in HeLa cells showed that the relocalization of MafG in nucleoli led to the relocalization of most P45 to the same sites (Fig. 7m-p) and thus proved the interaction of these two proteins when they are coexpressed in HeLa cells. Moreover, the relocalization of P45 to nucleoli when coexpressed with NoLS-MafG was clearly due to the interaction between P45 and MafG. Indeed, the expression of DsRed-NoLS in HeLa cells expressing GFP-P45 did not modify the localization of GFP-P45 (Fig. 7q-t) . In addition, coexpression of GFP-Sirtuin 1, a nuclear protein that possesses no affinity for MafG, with DsRed-NoLS-MafG did not change the localization of the former protein ( Fig. 7u-x ). In conclusion, we propose that adding the NoLS to one subunit of a nuclear protein complex makes it possible to target the entire complex to the nucleolus. Consequently, such an approach might be used to demonstrate protein interactions in a cellular context.
Discussion
A novel NoLS targets GFP to the nucleolus and interacts with B23
In this study, we generated a protein sequence which confers to GFP a specific nucleolar localization. This "synthetic" NoLS possesses no significant homology with the NoLSs previously described except for the presence of a stretch of basic residues as already reported for viral nucleolus-localizing proteins such as HIV-1 Rev (Kubota et al., 1989) , HIV-1 Tat (Dang and Lee, 1989) and HTLV-1 Rex (Siomi et al., 1988) and for cellular proteins such as the nucleolar protein p120 (Valdez et al., 1994) , Survivin-deltaEx3 (Song and Wu, 2005) and HSP70 (Dang and Lee, 1989) . As demonstrated by the localization of deletion mutants of this novel NoLS, the stretch of basic residues plays a key role in nucleolar localization.
Interestingly, as observed here, the capability of numerous proteins to adopt a nucleolar localization is correlated with their interaction with B23 (Adachi et al., 1993; Fankhauser et al., 1991; Korgaonkar et al., 2005; Li, 1997; Valdez et al., 1994) . Because of the ability of numerous nucleolar proteins to interact with B23 and because this major nucleolar protein shuttles constantly between nucleus and cytoplasm (Borer et al., 1989) , it was often suggested that B23 might be a transporter for nucleolar proteins possessing a NoLS (Fankhauser et al., 1991; Li, 1997; Valdez et al., 1994) . Even if this tempting hypothesis has never been demonstrated, recent results obtained on stable U2OS-derived cell lines with reduced B23 expression levels showed that the nucleolar localization of ARF is linked to B23 (Korgaonkar et al., 2005) . Indeed, the reduced expression of B23 induced a partial delocalization of ARF from nucleoli to nucleoplasm. The authors therefore concluded that B23 targets ARF to nucleoli in a dose-dependent manner. Nevertheless, this result does not make it possible to discriminate between a role of B23 in the transport of ARF from nucleoplasm to nucleoli and/or a role of B23 in the retention of ARF in nucleoli.
However, contrary to what had been suggested by several authors (Fankhauser et al., 1991; Li, 1997; Valdez et al., 1994) , a role of B23 in the transport of proteins to nucleoli does not seem mandatory. In fact, the recent analysis of the intranuclear dynamics of proteins in living cells has shown that nuclear proteins can diffuse within the nucleoplasm (Phair and Misteli, 2000; Sprague and McNally, 2005) . Concerning the nucleolus, it was demonstrated that nucleolar proteins rapidly associate with and dissociate from nucleolar components in a continuous exchange with the nucleoplasm (Chen and Huang, 2001; Dundr et al., 2004; Phair and Misteli, 2000; Snaar et al., 2000) . The authors suggest the existence of compartmentspecific retention mechanisms for proteins in nuclear bodies implying that the residence time of a particular molecule in a given nuclear body depends on its specific interactions (Misteli, 2001) . Consequently, protein interactions should govern the nuclear distribution of proteins and a NoLS might actually be a nucleolar molecule-interacting sequence.
A novel NoLS or a new B23-interacting sequence
The NoLS described here interacts with the central region of B23, i.e. the region including the two acidic stretches (amino acids 120 to 132 and 161 to 188) as already reported for HTLV-1 Rex (Adachi et al., 1993) . B23-NoLS interaction is direct and specific as demonstrated by the fact that the other nucleolar proteins tested showed no affinity for this novel NoLS. However, it seems unlikely that B23-NoLS interaction is only electrostatic occurring between the acidic stretches of B23 and the cluster of basic residues in NoLS. Indeed the other major nucleolar protein, nucleolin, that possesses four stretches of acidic residues in its N-terminal region does not interact with NoLS. Whatever type of interaction exists between B23 and NoLS, the affinity of NoLS for B23 in vitro was stronger than that of the HIV-1 Rev protein for B23.
Therefore, NoLS possesses a strong affinity for B23 in vitro and also in vivo as observed by the colocalization of the GFP-NoLS fusion and B23 in the GC of nucleoli during interphase, and by the fact that NoLS confers to GFP the behavior of B23 during mitosis. In addition, GFP-NoLS fusion and B23 remain colocalized after actinomycin D or roscovitine treatment. (Hu et al., 2002) . However, with both these methods only direct interactions are accessible.
Because conferring to a protein an additional strong affinity for B23 makes it possible to sequester and/or relocalize this protein to or within the nucleolus as verified for GFP, fibrillarin, MafG (this study) and CDK9 (our unpublished data), we hypothesized that such a approach might be used to relocalize a protein complex to or within the nucleolus. This hypothesis was proved correct by analyzing on one hand, two members of the core proteins of the box C/D snoRNP complexes, namely fibrillarin and Nop56, and on the other hand, the 
Materials and Methods
Cell culture, transfection, immunofluorescence
HeLa cells were cultured in MEM with GlutaMAX™ (Invitrogen) containing 10% FCS and NIH-3T3 cells in DMEM (Invitrogen) containing 10% FCS and 2 mM L-glutamine (Invitrogen) in a 5% CO 2 incubator at 37°C. Cells were transfected with purified plasmids using effectene (Qiagen) according to the manufacture's instructions. For synchronization in mitosis, HeLa cells were accumulated in prometaphase by nocodazole treatment (0.04 µg/ml for 3 hours), selectively harvested by mechanical shock, washed, and resuspended in nocodazole-free medium for 30 or 60 minutes. The drugs used were leptomycin B (Calbiochem) at 20 nM for 4 hours, roscovitine (Calbiochem) at 75 µM for 2 hours and actinomycin D (Sigma) at 0.1 µg/ml for 2 hours. For immunofluorescence, cells were plated on a coverslip in 6-well plates (Techno Plastic Products AG) and transfected 24 hours later. At 16-24 hours post transfection, the cells were fixed in 2% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.5% Triton X-100 for 5 minutes and prepared for fluorescence microscopy as previously described (Sirri et al., 2002) . Alternatively, the cells were fixed with 100% methanol for 10 minutes at -20°C, dried and rinsed several times with PBS before being incubated with antibodies. The antibodies used were goat polyclonal anti-B23 (Santa Cruz Biotechnology), mouse monoclonal anti-B23 (Sigma), a previously characterized human autoimmune serum with specificity against fibrillarin (O61; Sirri et al., 2002) and Texas Red-conjugated secondary antibodies specific for goat, mouse and human IgGs (Jackson ImmunoResearch Laboratories). Samples were incubated with 4,6-diamidino-2-phenylindole (DAPI) to visualize DNA and mounted with the antifading solution AF1 (Citifluor). Fluorescence microscopy was performed using a CCD camera Leitz DMRB and images assembled using Adobe Photoshop. Falini and N. Bolli (University of Perugia, Perugia, Italy) and corresponds to pEGFP-C1-NPMmA (Falini et al., 2005) . Fibrillarin-GFP and fibrillarin-RFP were obtained by PCRamplification from human cDNA and subcloning into the EcoRI/BamHI sites of pEGFP-N1 (Clontech) and pmRFP-N1 kindly provided by R.Y. Tsien (University of California, San Diego, USA). Fibrillarin cDNA and the DNA sequence of NoLS were fused by the "gene soeing" strategy and the PCR product subcloned into the EcoRI/BamHI sites of pEGFP-N1 and pmRFP-N1 to obtain respectively fibrillarin-NoLS-GFP and fibrillarin-NoLS-RFP. 
Pull down experiments
For in vitro pull down assays, the GST, GST-NoLS and GST-Rev proteins were overexpressed in E. coli (BL21 DE3) and then induced 3 hours with 0.1 mM IPTG at 37°C.
Lysates were obtained by enzymatic reaction with lysozyme (100 µg/ml) and DNase I (20 ng/µl) and clarified by ultracentrifugation at 65,000 g for 30 minutes. The clarified lysates were incubated with glutathione-sepharose beads (Amersham) for 2 hours at 4°C. GST fusion proteins bound to glutathione-sepharose beads were washed four times with wash buffer 1 (50 mM Tris-HCl pH 8, 1 M NaCl, 10% glycerol and complete) and once with binding buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.2% NP40, 10% glycerol and complete).
Complete corresponds to a cocktail of protease inhibitors (Roche). Proteins of HeLa cells transfected or not were extracted using lysis buffer (50 mM Tris-HCl pH 7.4, 500 mM NaCl, gentle shaking overnight at 4°C, the beads were centrifuged at 500 g for 2 minutes and washed four times in wash buffer 2 (50 mM Tris-HCl pH 7.4, 250 mM NaCl, 1 mM EDTA, 0.2% NP40, 10% glycerol and complete). In experiments comparing NoLS and Rev affinities, the incubations were performed for times varying from 1.5 to 20 hours. Purified B23 was produced by digestion of GST-B23 overexpressed in E. coli with thrombin (1 unit for 30 µl of beads) and purification on glutathione-sepharose beads as described above. For pull down assays performed with purified B23, the incubation time was 2 hours. In all cases, proteins corresponding to extracts recovered before and after pull down assays and proteins bound to beads were resuspended in SDS loading buffer, resolved by SDS-PAGE and analyzed by coomassie blue staining and immunoblotting. (A) GST and GST-NoLS pull down assays carried out using whole HeLa cell extracts. 1% of the extract used for each pull down assay (Input), 1% of the supernatant (S) and 1.5% of the proteins eluted from the bead pellet (P) after the indicated pull down assay were electrophoresed and immunoblotted to detect B23, Nopp140, Nucleolin and Nop52. B23 interacts specifically with GST-NoLS but not with GST. On the contrary, Nopp140, Nucleolin and Nop52 do not interact with GST-NoLS. (B) GST and GST-NoLS pull down assays carried out using a purified recombinant B23. 2% of the supernatant (S) and 3% of the proteins eluted from the bead pellet (P) after the indicated pull down assay were 
